Topic 12 of 20
GS Paper 3 Antimicrobial Resistance WHO AWaRe classification and antibiotic stewardship gaps in India

India uses 9.3 defined daily doses of "Watch" antibiotics per 1,000 people, against an estimated need of just 6. Meanwhile "Access" antibiotics, the first-line drugs meant to treat most infections, are used at barely half the ideal rate. The imbalance, not the total volume, is the real story.

Summary

A study published in The Lancet Public Health has found that India's antibiotic consumption is heavily skewed toward "Watch" category drugs, powerful, broad-spectrum antibiotics meant to be reserved for specific infections, while both first-line "Access" antibiotics and last-resort "Reserve" drugs remain underused. The findings echo an earlier NCDC hospital survey showing that only 6% of prescriptions were based on actual culture testing, meaning most antibiotics are being started without confirming what infection, if any, is actually present.

WHY IN NEWS FOR UPSC & STATE PCS

The Lancet Public Health study is the first global framework estimating how much of each antibiotic category countries actually need based on their infection burden and it places India's prescribing pattern sharply out of line with that estimate: overusing Watch antibiotics, underusing Access antibiotics and underusing Reserve antibiotics despite the country's high resistance burden.

Standard News

The Missing Step Before the Prescription Pad Here's the

AWaRe classification in one line: WHO sorts antibiotics into Access (safe, first-line, low resistance risk), Watch (stronger, meant only for specific infections) and Reserve (last resort, for confirmed multidrug-resistant cases).

It's a traffic-light system for how carefully a drug should be guarded. India's numbers show the light is stuck on the wrong colour: 9.3 defined daily doses of Watch antibiotics used per 1,000 people, against an ideal of 6.

Access antibiotics, meanwhile, are used at 4.5 DID against a required 7.8. That's not simply "too many antibiotics." India's overall use, 18.3 DID against an ideal 14.7, is actually closer to appropriate than the category mix suggests.

The real problem is a category swap: doctors are reaching for the strong drug first and the mild first-line drug is being underused. Why would a doctor reach for the stronger drug by default? Because the alternative is diagnosis and diagnosis takes time an emergency department or an overloaded ward doesn't have.

The NCDC's own hospital survey found only 6% of antibiotic prescriptions were based on an actual culture test confirming which organism was present. The other 94% were "empirical," a doctor's best guess at what infection this probably is, treated with a drug broad enough to cover several possibilities at once.

A Watch antibiotic is, by design, that broad-coverage guess. An Access antibiotic usually isn't, which is exactly why it's safer to overuse and riskier to under-target with. This is where the AWaRe framework earns its relevance, not as a WHO classification exercise but as a diagnostic mirror.

It doesn't just describe the problem, it locates it precisely: at the point of prescription, before any lab result comes back, in wards where 86.5% of antibiotics are still given intravenously and prescribing rates swing from 37% to 100% depending on the hospital.

That range alone tells you this isn't a drug-availability problem. It's a decision-point problem, repeated at scale, without the microbiology infrastructure to slow it down. What's actually missing isn't awareness. India has had a National Action Plan on AMR since 2017 and doctors broadly know what "Watch" and "Reserve" mean.

What's missing is the turnaround-time infrastructure, fast, affordable culture testing at the point of care, that would let a physician start narrow and confirm, instead of starting broad because narrow isn't fast enough to be practical.

For the exam, the AWaRe skew isn't just a fact to cite, it's the clearest available proxy for how far a health system still runs on guesswork instead of confirmed diagnosis and that gap is exactly what any answer on India's AMR governance should be measuring.

Quick Facts

  • India's actual antibiotic use is 18.3 defined daily doses per 1,000 people per day against an ideal requirement of 14.7. Only 27% of use comes from the Access category against a required 52.3%. An earlier NCDC survey across 20 tertiary hospitals found 57% of prescriptions were Watch antibiotics and only 6% were based on microbiological culture confirmation.

    Common overused Watch drugs include ceftriaxone, azithromycin and ciprofloxacin. Reserve antibiotics such as meropenem and colistin should be limited to confirmed multidrug-resistant infections.

Beyond The Headlines
GS Paper 3 WHO AWaRe classification and antibiotic stewardship gaps in India

Connect the dots for your UPSC preparation.

Standard news covers the event. Log in to read our comprehensive analysis and uncover the hidden constitutional, structural, and ethical dimensions of this topic:

1

The specific hospital-level evidence showing why 94% of prescriptions are empirical, not diagnosis-confirmed

2

The full breakdown of duplicate antibiotic coverage and what it reveals about India's stewardship gaps

3

A concrete short-term and long-term roadmap tied to the National Action Plan on AMR

4

The tertiary-hospital case study showing exactly where stewardship infrastructure breaks down at the point of prescription

Included in this analysis

Deep Analysis Sharpens your Mains-level understanding.
8 Languages Read the news comfortably in your language.
PYQ Connection Direct connection with previous year Mains questions.
Expected Questions Possible upcoming questions for Prelims & Mains.
Daily Evaluation Daily Prelims test, plus category-wise Mains evaluation.
Mentor Observation Daily, topic-wise expert feedback on your tests.
Value Additions Important Case Studies and daily Vocab Word.

Join thousands of aspirants analyzing the news deeply.

Log In to Read Full Article

More from 24 Jul 2026

Short titles by category — open any story to read it fully.

GS Paper 2
Protest Policing, the Ramlila Maidan Safeguards and a Split Judicial Response Two courts, one march, one Wednesday - the Delhi High Court ordered every second of CCTV footage from July 20 preserved, while the Supreme Court's Chief Justice told a lawyer holding the same videos, "we don't have time to watch them." The Merger Exception, Paragraph 4 and the Speaker's Discretion An MP wins a Lok Sabha seat on one party's ticket, one symbol, one leader's name on the ballot - and then, without ever formally leaving that party, ends up sitting with its rival. What does the Constitution actually call that? Indirect Discrimination Through Tax Law - Section 56(2)(x) of the Income Tax Act Two software engineers in Bengaluru have shared a home since 2019. When one gifted the other a gold bracelet worth a little over a lakh, the tax office wanted 25 percent of its value - because the law does not recognise them as spouses or even as relatives. Safeguards Against Arbitrary Disenfranchisement in the ASDDO Flagging Process Somewhere inside Karnataka's 47 lakh flagged voters is a person who genuinely did move house and another who genuinely didn't. The number treats them identically. What happens next is the part that actually decides whether either one loses their vote. Article 262 and the Limits of Technical Adjudication During a Deficit Year The Cauvery Water Management Authority exists to make water-sharing a technical, not political, exercise. This week it had to order Karnataka and Tamil Nadu to stop sharing almost entirely - because for the first time in years, there is barely enough for either state to drink. The Gap Between Diplomatic Normalisation and Economic Rebalancing $112.16 billion - that's how much more India bought from China than it sold back in 2025-26. In the same year Jaishankar told Wang Yi in Manila that "differences should not become disputes." Both statements are true. Only one of them is a fact the other side can't negotiate its way around. ASI Surveys as a Judicial Tool at Contested Religious Sites A group of worshippers in Dhar spent weeks walking nearly two kilometres each Friday to offer namaz at a spot the state government insisted was close enough. This week, the Supreme Court told the state it wasn't.